Barbara Fingleton

11PUBLICATIONS
16CO-AUTHORS
Haematological tumoursPredictive and prognostic markersWomen's studies (incl. girls' studies)Cancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 06, 2025
TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Elysa W Pierro, Guadalupe A Garcia, Violeta M Sanchez

|Jul 15, 2025
Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling.

Wendy E Bindeman, Kevin C Corn, Marjan Rafat

|Jan 22, 2025
Comparison of Lean, Obese, and Weight-Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T-cell Populations.

Elysa W Pierro, Matthew A Cottam, Hanbing An

|Dec 17, 2024
Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model.

Ebony Hargrove-Wiley, Dora Obodo, Wendy Bindeman

|Oct 10, 2024
Trem2 deficiency attenuates breast cancer tumor growth in lean, but not obese or weight loss, mice and is associated with alterations of clonal T cell populations.

Elysa W Pierro, Matthew A Cottam, Hanbing An

|May 11, 2024
Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.

Demond Williams, Ebony Hargrove-Wiley, Wendy Bindeman

Pageof 2

Frequent Collaborators

3 joint publications

Ebony Hargrove-Wiley

3 joint publications

Elysa W Pierro

3 joint publications

Alyssa H Hasty

2 joint publications

Matthew A Cottam